에 대한 최신 뉴스 Clarivate (NYSE:CLVT) 주식

Clarivate

Clarivate is a data, information, and software workflow solutions company serving customers primarily in academia, government, law, life sciences, and healthcare. The company was formerly part of Thomson Reuters before being sold to private equity as an independent company in 2016. In 2019, Clarivate went public on the New York Stock Exchange. Around half of the company's revenue is generated in the Americas while Europe, Middle East, and Africa account for around a quarter.

Equities

Broad U.S. Equity ETFs

Emerging Markets

Specialty ETFs

Emerging Market ETFs

Commodities

Politics

Global

Econ #s

Markets

Movers

ETFs

ALAB

BBWI

CLVT

SPDR Dow Jones Industrial Average ETF Trust

ISRA

SMCI

WOLF

이스라엘과 레바논은 이스라엘과 헤즈볼라 간의 1년 넘는 폭력적 충돌을 종식시키기 위한 휴전 협정의 틀에 합의했다고 한 고위 미국 관리가 월요일 아침 악시오스(Axios)에 전했다.

이스라엘·레바논, 휴전 협정 도달: 금 및 유가 하락, S&amp;P 500과 다우존스가 최고치 경신

Clarivate PLC

News

Guidance

ABBV

CORRECTION: AbbVie Sees FY25 Adj. EPS $12.12-$12.32 vs $12.18 Est.; Reaffirms Long-Term Revenue Growth Outlook of High Single-Digit CAGR Through 2029

Deutsche Bank analyst Sidney Ho maintains KLA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KLAC#NASDAQ">KLAC</a>) with a Buy and raises the price target from $725 to $850.

Price Target

Analyst Ratings

KLAC

Deutsche Bank Maintains Buy on KLA, Raises Price Target to $850

HC Wainwright &amp; Co. analyst Raghuram Selvaraju maintains Axsome Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AXSM#NASDAQ">AXSM</a>) with a Buy and raises the price target from $180 to $190.

AXSM

HC Wainwright & Co. Maintains Buy on Axsome Therapeutics, Raises Price Target to $190

Needham analyst Quinn Bolton reiterates Intel (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>) from Hold to Hold.

Reiteration

INTC

Needham Reiterates Hold on Intelto Hold

B of A Securities analyst Jason Kupferberg maintains Visa (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/V#NYSE">V</a>) with a Neutral and raises the price target from $331 to $363.

B of A Securities Maintains Neutral on Visa, Raises Price Target to $363

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Baird analyst Benjamin Hartford downgraded the rating for United Parcel Service, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UPS#NYSE">UPS</a>) from Outperform to Neutral and lowered the price target from $160 to $130. UPS shares closed at $114.90 on Thursday. <a href="https://www.benzinga.com/quote/UPS/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Goldman Sachs analyst Neil Mehta downgraded Occidental Petroleum Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OXY#NYSE">OXY</a>) from Neutral to Sell and slashed the price target from $54 to $45. Occidental Petroleum shares closed at $48.92 on Thursday. <a href="https://www.benzinga.com/quote/OXY/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Piper Sandler analyst Michael Lavery downgraded the rating for The Hershey Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HSY#NYSE">HSY</a>) from Neutral to Underweight and cut the price target from $153 to $120. Hershey shares closed at $152.14 on Thursday. <a href="https://www.benzinga.com/quote/HSY/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>B of A Securities analyst Jessica Reif Cohen downgraded Comcast Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMCSA#NASDAQ">CMCSA</a>) from Buy to Neutral and lowered the price target from $50 to $38. Comcast shares closed at $33.25 on Thursday. <a href="https://www.benzinga.com/quote/CMCSA/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Truist Securities analyst Neal Dingmann downgraded the rating for Murphy Oil Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MUR#NYSE">MUR</a>) from Buy to Hold and lowered the price target from $42 to $31. Murphy Oil shares closed at $27.47 on Thursday. <a href="https://www.benzinga.com/quote/MUR/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying OXY stock? Here&#8217;s what analysts think: 
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/01/43335398/wall-streets-most-accurate-analysts-spotlight-on-3-risk-off-stocks-delivering-high-dividend-yields">Wall Street&#8217;s Most Accurate Analysts Spotlight On 3 Risk Off Stocks Delivering High-Dividend Yields</a></li>
</ul>

Downgrades

Pre-Market Outlook

Trading Ideas

CMCSA

This Occidental Petroleum Analyst Turns Bearish; Here Are Top 5 Downgrades For Friday

HC Wainwright &amp; Co. analyst Patrick Trucchio reiterates Vir Biotechnology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VIR#NASDAQ">VIR</a>) with a Buy and maintains $110 price target.

HC Wainwright & Co. Reiterates Buy on Vir Biotechnology, Maintains $110 Price Target

B of A Securities analyst Ken Hoexter maintains United Parcel Service (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UPS#NYSE">UPS</a>) with a Buy and lowers the price target from $150 to $133.

B of A Securities Maintains Buy on United Parcel Service, Lowers Price Target to $133

Needham analyst Joseph Stringer reiterates Vertex Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRTX#NASDAQ">VRTX</a>) from Hold to Hold.

VRTX

Needham Reiterates Hold on Vertex Pharmaceuticalsto Hold

23andMe Holding Released New Polygenic Risk Score Report On The Genetics Of Osteoporosis For 23andMe+ Premium Members

WIIM

AbbVie shares are trading higher following better-than-expected Q4 financial results.

HC Wainwright &amp; Co. analyst Patrick Trucchio reiterates Mind Medicine (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNMD#NASDAQ">MNMD</a>) with a Buy and maintains $55 price target.

MNMD

HC Wainwright & Co. Reiterates Buy on Mind Medicine, Maintains $55 Price Target

A new player in the AI arena, DeepSeek, has unveiled an open-source language model, R1, that experts say is a game-changer in efficiency, raising questions about the <a href="https://www.benzinga.com/markets/cryptocurrency/25/01/43244653/bitcoin-ethereum-solana-crash-heres-why-chinas-low-cost-ai-model-deepseek-may-be-to-blame">future of AI development.</a>
<h2 class="wp-block-heading">The DeepSeek Effect</h2>
Developed for under $6 million, DeepSeek&#8217;s R1 has not only outperformed established competitors in several tests but has also called into question the established big-spending approach prevalent in Silicon Valley. 
This development has triggered a mix of optimism about democratized AI and fears of an AI stock bubble bursting, sending ripples throughout financial markets.
&#8220;Another DeepSeek is hiding in plain sight,&#8221; said Roi Ginat, CEO of Endless AI, a multimodal AI company, highlighting DeepSeek's influence in making impactful AI with limited resources. 
Ginat&#8217;s own company, EndlessAI, has been working on efficient video processing, echoing DeepSeek's stand to using LLMs in practical, cost-effective ways. 
Ginat told Benzinga that EndlessAI provides the tools to make existing models work smarter by using proprietary video transfer optimization which enables massive cost reduction for video processing, adding that this is complementary, not competitive, with what DeepSeek is doing.
Speaking with Benzinga, Satya Nitta, CEO of Emergence AI, an AI orchestration company, echoed the sentiment, calling DeepSeek R1 a &#8220;meaningful advance in broadening access to AI reasoning.&#8221; 
Nitta emphasized the importance of open-source solutions that are not only trusted but also scalable and adaptable to evolving needs.
Matthew Putman, CEO of Nanotronics, an industrial AI company, told Benzinga that DeepSeek&#8217;s achievement demonstrates that &#8220;it is possible to do more with less,&#8221; suggesting that resource constraints may fuel innovation. 
Putman sees these developments as essential for broader adoption of AI for industries beyond just text generation, stressing it's critical for advancing semiconductor production, which makes AI technology possible.
Mitesh Agrawal, CEO of Positron, an AI hardware company, pointed to DeepSeek&#8217;s success as evidence that &#8220;inference-time compute is the new scaling factor&#8221; in AI development, delivering real results with optimized systems. 
Agrawal told Benzinga that performance per dollar and performance per watt are critical to make the best AI models accessible.
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/25/01/43356514/helix-debuts-ai-index-perpetual-market">Helix Debuts AI Index Perpetual Market, Bridging Crypto And Traditional Equities On-Chain</a>
<h2 class="wp-block-heading">Is DeepSeek A Cause For Concern?</h2>
However, concerns also accompany this disruptive innovation.
Speaking with Benzinga, Pukar Hamal, CEO of SecurityPal, an AI-enhanced security review company, warned about the security and regulatory implications of an "open-source" model with unknown alignment. 
Hamal highlighted the &#8220;gas law&#8221; of computing, whereby cheaper compute expands markets, but also stressed the need for guardrails to protect the public and maintain compliance.
These concerns translated into market jitters on the day DeepSeek news first broke.
The Nasdaq Composite dropped 2.7% on Monday, the S&amp;P 500 slid 1.6% and the Dow Jones Industrial Average dipped 0.1% following the DeepSeek announcement.
The announcement of a new low-cost, high-performance open source AI model that competes with existing proprietary AI systems also drove volatility in the cryptocurrency market. 
Crypto markets also took a hit, with Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) falling 5.5% and Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>) dropping 7% on Monday before recovering.
Other major altcoins also experienced significant losses, as traders grappled with the potential implications of DeepSeek&#8217;s emergence.
On Monday, altcoins like Solana (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/sol/usd">SOL</a>), BNB (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/bnb/usd">BNB</a>), Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>) and Cardano (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/ada/usd">ADA</a>) were down 11%, 3.5%, 9% and 8.5%, respectively.
<h2 class="wp-block-heading">What&#8217;s Next For DeepSeek</h2>
DeepSeek's disruptive impact is already rippling through financial markets. 
The sharp declines in AI-related stocks and cryptocurrencies suggest that investors are reassessing the sustainability of current AI valuations. 
Analysts warn that DeepSeek's ability to deliver high-performance AI at a fraction of traditional costs may force industry leaders to rethink their strategies.
Moreover, experts believe DeepSeek's approach could reshape the $25 billion computer vision market and redefine the scalability of AI applications. 
As companies continue to push the boundaries of multimodal AI, the industry appears poised for a shift toward leaner, more efficient AI models that can thrive outside the confines of billion-dollar research labs.
In the face of this transformation, the question remains: will legacy AI firms adapt to the new paradigm, or will DeepSeek's breakthrough mark the beginning of a broader industry upheaval?
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/01/43351797/grayscale-seeks-sec-approval-to-convert-xrp-trust-into-exchange-traded-fund">Grayscale Seeks SEC Approval To Convert XRP Trust Into Exchange-Traded Fund</a></li>
</ul>
Image created using artificial intelligence with Midjourney.

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$ADA

$BNB

$BTC

$DOGE

$ETH

$SOL

Experts Say DeepSeek Proves High-Performance AI Possible Without Silicon Valley's Spending

AbbVie Sees FY25 Adj. EPS $12.12-$12.32 vs $10.08 Est.; Reaffirms Long-Term Revenue Growth Outlook of High Single-Digit CAGR Through 2029

YMAB

Y-mAbs Therapeutics Says It Will Present Preclinical And Translational Pharmacokinetics Data Of GD2-SADA In A Poster At Society Of Nuclear Medicine & Molecular Imaging Mid-winter And American College Of Nuclear Medicine Annual Meeting

Hitachi (OTC:<a class="ticker" href="https://www.benzinga.com/stock/HTHIY#OTC">HTHIY</a>) reported its Q3 earnings results on Friday, January 31, 2025 at 07:00 AM.
Here's what investors need to know about the announcement.
<h3>Earnings</h3>
Hitachi missed estimated earnings by -9.0%, reporting an EPS of $0.4 versus an estimate of $0.44.
Revenue was up $903.00 million from the same period last year.
<h3>Historical Earnings Summary</h3>
In the previous quarter, the company missed on EPS by $0.07, resulting in a 5.0% increase change in the share price the following day.
Here's a look at Hitachi's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.41</td>
<td>0.05</td>
<td>0.33</td>
<td>0.34</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.34</td>
<td>0.49</td>
<td>1.02</td>
<td>0.64</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>15.82B</td>
<td>12.27B</td>
<td>15.53B</td>
<td>13.49B</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>15.68B</td>
<td>14.19B</td>
<td>18.68B</td>
<td>15.28B</td>
</tr>
</tbody>
</table>

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Guidance</h3>
Hitachi management provided guidance for FY 2024, expecting earnings between $0.91 and $0.91 per share.
To track all earnings releases for Hitachi <a href="https://www.benzinga.com/quote/HTHIY/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings

HTHIY

Earnings Summary: Hitachi Q3

AbbVie (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABBV#NYSE">ABBV</a>) reported quarterly earnings of $2.16 per share which beat the analyst consensus estimate of $2.11 by 2.37 percent. This is a 22.58 percent decrease over earnings of $2.79 per share from the same period last year. The company reported quarterly sales of $15.102 billion which beat the analyst consensus estimate of $14.827 billion by 1.85 percent. This is a 5.60 percent increase over sales of $14.301 billion the same period last year.

Earnings Beats

AbbVie Q4 2024 Adj. EPS $2.16 Beats $2.11 Estimate, Sales $15.102B Beat $14.827B Estimate

HC Wainwright &amp; Co. analyst Joseph Pantginis reiterates Lineage Cell Therapeutics (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/LCTX#AMEX">LCTX</a>) with a Buy and maintains $9 price target.

LCTX

HC Wainwright & Co. Reiterates Buy on Lineage Cell Therapeutics, Maintains $9 Price Target

First BanCorp. Reveals Strategic Reorganization Aligned With Corporate Succession Plan Aimed At Improving Operational Efficiency, Enhancing Customer Experience, And Driving Business Transformation To Align Resources For Growth

HC Wainwright &amp; Co. analyst Edward White reiterates Valneva (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VALN#NASDAQ">VALN</a>) with a Buy and maintains $18 price target.

VALN

HC Wainwright & Co. Reiterates Buy on Valneva, Maintains $18 Price Target

Clarivate (CLVT) announced that Daikin Industries has selected IPfolio from Clarivate. The air conditioner manufacturer will utilize this solution ...

Clarivate announces Daikin Industries selects IPfolio

Morgan Stanley analyst Toni Kaplan maintained a Hold rating on Clarivate (CLVT – Research Report) today and set a price target of $5.00. The compan...

Morgan Stanley Remains a Hold on Clarivate (CLVT)

Clarivate sets $500M stock repurchase plan

Clarivate (CLVT) announced that its Board of Directors authorized a new share repurchase program of up to $500 million of the Company's outstanding...

Clarivate announces new $500M share repurchase authorization

Worst performing stocks for tax loss selling – Wolfe

Clarivate ( ($CLVT) ) has provided an announcement. Clarivate Plc announced a new share repurchase program authorizing the buyback of up to $500 mi...

Clarivate Announces $500M Share Buyback Program

Clarivate: Clearing The Decks

In a report released today, Surinder Thind from Jefferies maintained a Buy rating on Clarivate (CLVT – Research Report), with a price target of $7....

Jefferies Remains a Buy on Clarivate (CLVT)

Clarivate (CLVT) announced that the British Library has selected Clarivate to provide its library services and discovery platforms to create a more...

Clarivate selected by British Library to provide library services

RBC Capital analyst Ashish Sabadra maintained a Hold rating on Clarivate (CLVT – Research Report) yesterday and set a price target of $6.00. The co...

RBC Capital Sticks to Their Hold Rating for Clarivate (CLVT)

ACHC

ACLS

AGCO

ALGM

AMKR

APLS

ATKR

BIIB

BMRN

BRBR

CNXC

COLD

DINO

DXCM

ENPH

FIVN

FLNC

IONS

IPGP

MCHP

MRNA

NEOG

OPCH

PTEN

QDEL

QRVO

REGN

REXR

SEDG

SGRY

STNE

SWKS

SYNA

XRAY

Press Releases

Daikin Selects IPfolio from Clarivate

Clarivate and the Chinese Academy of Sciences Release Annual Collaborative Report to Identify 125 Research Fronts

Clarivate Launches AI-Powered Patent Search Solution in Derwent

Clarivate Announces New $500 Million Share Repurchase Authorization

Clarivate Identifies Eleven Potential Blockbuster and Transformative Drugs in Annual Drugs to Watch Report

Clarivate Launches DRG Fusion - A New Life Sciences Analytics Product Powered by Real-World Data

BioWorld by Clarivate Releases Comprehensive 2024 Year in Review

Clarivate to Report Fourth Quarter and Full Year 2024 Results on February 19, 2025

Contracts

The British Library Selects Clarivate to Provide Library Services and Discovery Platforms

Clarivate identifies top 50 universities powering global innovation

Amentum Holdings

Booz Allen Hamilton Holding Corporation Common Stock

Booz Allen Hamilton

CACI International, Inc. Class A Common Stock

CACI International

CBIZ

CRA Intl

Dun & Bradstreet Holdings, Inc. Common Stock

Dun & Bradstreet Hldgs

Equifax

Exponent

FTI Consulting

Huron Consulting Group Inc. - Common Stock

Huron Consulting Gr

ICF International

Innodata

Jacobs Solutions

Leidos Holdings

LegalZoom.com

NV5 Global

Planet Labs

Parsons

RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share)

RELX

Science Applications International Corporation - Common Stock

Science Applications Intl

TransUnion

UL Solutions

Verisk Analytics

Willdan Group

RBC Capital

Barclays

Goldman Sachs

Morgan Stanley

Oppenheimer

이스라엘과 레바논은 이스라엘과 헤즈볼라 간의 1년 넘는 폭력적 충돌을 종식시키기 위한 휴전 협정의 틀에 합의했다고 한 고위 미국 관리가 월요일 아침 악시오스(Axios)에 전했다.
이 협정은 화요일 이스라엘의 안전 보장 내각의 공식 승인을 기다리고 있지만, 글로벌 금융 시장은 이미 반응을 보이고 있다. 지정학적 위험이 줄어들면서 금과 유가가 급락하고, <a href="https://www.benzinga.com/topic/israel">투자자들의 낙관적 전망이 개선되고 있는 가운데</a> 위험 자산의 가치가 상승하고 있다. <a href="https://www.benzinga.com/topic/israel"> </a>
다우존스 지수와 S&amp;P 500 지수는 월요일 뉴욕에서 시장이 개장한 직후 몇 분 만에 최고가를 경신했다.
<h3 class="wp-block-heading">이스라엘-레바논 협정: 내용</h3>
휴전이 승인된다면, 3,500명 이상의 레바논인과 140명의 이스라엘인이 목숨을 잃고 국경 양쪽에서 수십만 명이 피란 생활을 하게 된 끔찍한 장이 끝나는 것을 의미한다.
이 제안된 협정에 따르면, 이스라엘은 남부 레바논에서 군 철수를 60일간 시작하고, 악시오스의 <a href="https://www.axios.com/2024/11/25/israel-lebanon-near-hezbollah-ceasefire-deal">보도</a>에 따르면, 레바논 군은 국경 지역에 배치되며 헤즈볼라는 리타니 강 북쪽으로 중무기를 이전해야 한다.
협정 준수를 보장하기 위해, 미국 주도의 감독 위원회가 협정을 모니터링하고, 레바논군이 행동하지 않을 경우 미국이 이스라엘 군사 작전을 지원하겠다고 약속했다.
한 고위 미국 관리가 악시오스에 말했다: &#8220;우리는 협정이 되었다고 생각한다. 하지만 우리는 골라인에 있지만 아직 지나지 않았다.&#8221;
<h3 class="wp-block-heading">유가, 금 가격 급락</h3>
이 소식은 원자재 시장에 충격파를 보냈다.
더 넓은 지역 갈등의 위협이 줄어들면서, United States Oil Fund(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USO#NYSE">USO</a>)가 추적하는 서부 텍사스 중질유(WTI) 가격이 월요일에 배럴당 70달러로 1.5% 하락하며 금요일의 상승폭을 거의 완전히 반납했다.
SPDR 금 ETF(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLD#NYSE">GLD</a>)가 추적하는 금 가격은 안전 자산에 대한 베팅이 축소되면서 온스당 2,640달러로 3% 이상 급락했다. 은 가격도 3% 하락하여 온스당 30.40달러로 거래되었다.
미국 달러도 약세를 보이며 주요 통화 바스켓 대비 0.7% 하락하여 위험 심리의 변화를 반영했다.
<h3 class="wp-block-heading">주식 시장, 새로운 고점으로 상승</h3>
휴전 낙관론이 주식 시장으로 확산되었다. SPDR S&amp;P 500 ETF Trust(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>)가 추적하는 S&amp;P 500 지수 6,020포인트로 사상 최고치를 기록하며 이날 0.8% 상승했고, SPDR 다우존스 산업평균지수 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>)가 추적하는 다우존스 산업평균지수 1% 상승하여 44,738로 신고가를 기록했다.
모든 주요 S&amp;P 섹터가 상승했으며, 에너지 섹터를 제외한 모든 섹터가 상승했다. 더 넓은 지수는 여섯 번째 연속 상승세를 목표로 하고 있다.
VanEck 이스라엘 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ISRA#NYSE">ISRA</a>)가 추적하는 이스라엘 주식은 1.9% 상승하여 여섯 번째 연속 상승세를 보였다.
월요일 뉴욕에서 거래 중 S&amp;P 500의 주요 상승 종목은 다음과 같다:
<ul>
<li>배스 앤 바디웍스 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBWI#NYSE">BBWI</a>)</li>
<li>슈퍼 마이크로 컴퓨터 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>)</li>
<li>울프스피드 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WOLF#NYSE">WOLF</a>)</li>
<li>클래리베이트 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLVT#NYSE">CLVT</a>)</li>
<li>아스테라 랩스 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALAB#NASDAQ">ALAB</a>)</li>
</ul>
다음 읽어보기:
<ul>
<li><a href="https://kr.benzinga.com/news/usa/indices/%EB%B1%85%EA%B0%80%EB%93%9C%EC%9D%98-sp-500-etf%EB%8A%94-2024%EB%85%84%EC%97%90-1000%EC%96%B5-%EB%8B%AC%EB%9F%AC-%EC%9C%A0%EC%9E%85-%EA%B8%B0%EB%A1%9D-spy%EC%9D%98-1%EC%9C%84-%EC%9E%90%EB%A6%AC/" target="_blank" rel="noopener">2024년 뱅가드 S&amp;P 500 ETF 1000억 달러 유입: SPY의 왕관이 위험에 처했는가?</a></li>
</ul>
사진 출처: Shutterstock.
다른 트레이더들보다 30분 일찍 독점 시장 움직임 뉴스를 받아보세요. 
Benzinga Pro의 14일 무료 체험을 통해 독점 뉴스 기사를 이용할 수 있어 수백만 명의 다른 트레이더보다 먼저 실행 가능한 거래 뉴스를 얻을 수 있습니다. <a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noreferrer noopener">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

이스라엘·레바논, 휴전 협정 도달: 금 및 유가 하락, S&P 500과 다우존스가 최고치 경신

Comments

Clarivate

뉴스

에 대한 최신 뉴스 Clarivate (NYSE:CLVT) 주식

월요일, 11월 25, 2024

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌